Zimmer Biomet Prepares for Longer Downturn

Zimmer Biomet reported 3Q21 orthopedic revenue of $1,720 million, -0.5% vs. 3Q20. Compared to the same period in 2019, the company's orthopedic revenue grew by +0.9%. Because of worse-than-expected market conditions, Zimmer Biomet lowered its 2021 revenue guidance from reported growth of 14.5% to 16.5% to a range of 11.3% to 12.5%.


document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us